Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines.
He, L., Tzarum, N., Lin, X., Shapero, B., Sou, C., Mann, C.J., Stano, A., Zhang, L., Nagy, K., Giang, E., Law, M., Wilson, I.A., Zhu, J.(2020) Sci Adv 6: eaaz6225-eaaz6225
- PubMed: 32494617 
- DOI: 10.1126/sciadv.aaz6225
- Primary Citation of Related Structures:  
6UYD, 6UYF, 6UYG, 6UYM - PubMed Abstract: 
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are responsible for cell entry, with E2 being the major target of neutralizing antibodies (NAbs). Here, we present a comprehensive strategy for B cell-based HCV vaccine development through E2 optimization and nanoparticle display ...